| Cas No.: | 1569304-29-5 |
| Synonyms: | POL-5551;POL 5551 |
| Purity: | >98% |
| Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Description: | A novel peptidic, potent and highly selective CXCR4 antagonist with IC50 of 1.7 nM; displays about 200-fold lower than Plerixafor (IC50=400-600 nM), and mobilizes hematopoietic stem and progenitor cells (HSPCs) with greater efficiency than Plerixafor, does not induce major morphological changes in the BM of mice; reduces the migration of breast cancer cells in vitro, and reduces metastasis and prolongs survival in mice.HIV InfectionDiscontinued |

To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
